Figure 1
Figure 1. Investigator-assessed response to treatment using IMWG criteria. BORT, bortezomib; CR, complete response; LEN, lenalidomide; VGPR, very good partial response.

Investigator-assessed response to treatment using IMWG criteria. BORT, bortezomib; CR, complete response; LEN, lenalidomide; VGPR, very good partial response.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal